Improving policies that affect endocrine scientists and their research.
The Endocrine Society works with the federal government, research funding agencies, and regulatory bodies to advance progress in biomedical research and to ensure the latest findings from endocrine scientists are incorporated into research strategic plans. Our goals aim to ensure that the full body of research available is available to policymakers and that the research will affect positive change by advocating for increased research and updated regulatory processes. Research advocacy efforts include biomedical research funding, stem cell research, central IRBs, and clinical trial registries. Read our position statements. Our advocacy comes in the form of various policy communications, including advocacy letters, both our own and as part of coalitions. We also provide testimony and friend-of-the-court briefs. All communications can be found on our Advocacy page or below.
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.
Congress has yet to complete the appropriations process for Fiscal Year (FY) 2024, and the clock is ticking on two issues important to endocrinology: funding for the National Institutes of Health (NIH) and funding for the Special Diabetes Program (SDP). We need ALL U.S. members of the Endocrine Society to join our campaign to urge Congress to complete the appropriations process for FY 2024 and protect NIH funding, extend SDP, and provide a funding increase for NIH in FY 2025. All Members of Congress need to hear these messages today.